Oncotelic Therapeutics, Inc. Short-term Debt
Oncotelic Therapeutics, Inc. (OTLC) had Short-term Debt of $2.72 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Short-Term Debt
us-gaap:ShortTermBorrowings · last filed 2025-08-13
- 2025-06-30: Short-term Debt $2.72M.
- 2025-03-31: Short-term Debt $2.58M.
- 2024-12-31: Short-term Debt $2.42M.
- 2024-09-30: Short-term Debt $2.38M.
| Period end | Short-term Debt |
|---|---|
| 2025-06-30 | $2.72M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.58M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.42M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $2.38M 10-Q · filed 2024-11-19 |
| 2024-06-30 | $2.16M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.02M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.77M 10-K · filed 2025-04-15 |
| 2023-09-30 | $1.47M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.08M 10-Q · filed 2023-08-18 |
| 2023-03-31 | $590.05K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $390.05K 10-K · filed 2024-04-12 |
| 2022-06-30 | $268.17K 10-Q · filed 2022-08-22 |
| 2022-03-31 | $295.05K 10-Q · filed 2022-05-23 |
| 2021-12-31 | $359.26K 10-Q · filed 2022-08-22 |
| 2021-09-30 | $343.24K 10-Q · filed 2021-11-22 |
| 2021-06-30 | $764.88K 10-Q · filed 2021-08-20 |
| 2021-03-31 | $140.00K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $95.00K 10-K · filed 2022-04-15 |
| 2020-09-30 | $70.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $70.00K 10-Q · filed 2020-08-14 |